Innobiochips gathers talented and seasoned managers and partners that steer the company’s growth and ensure stable strategic development.
Stéphane DUTHOIT, 55, has managed biotech companies for 26 years. He is a DVM with an MBA and turned around successfully 5 companies.
Vianney SOUPLET, 37, Co-founder, is focusing on Business development. PhD in Biology, trained in management of innovation prior to creating Innobiochips.
Christophe OLIVIER, 44, Co-founder, is running the technical development part. He has a PhD in Chemistry, published several papers and patents on biochips technology.
François-René LETOURNEUR, is CEO of Finovam, and an experienced venture capital investor and manager with board experience in accelerated growth situations. M&A experience in deal structuring, negociation and closing. He has an engineer's Degree and an MBA.
Claude GRENIER, Business development at Genes Diffusion, Canadian, Claude is well- known in the agro industry. He managed PIC in Europe.
Eric HALIOUA, Advisor, Eric has a DEA in molecular biology and pharmacology and a MBA. He has been principal at the management consulting company Arthur D. Little prior and co-founder of Myosix and Murigenetics. He has been CEO of Promethera Biosciences (Belgium) and is seating in several biotech companies’ boards.
Denis HENRARD, Advisor, Denis has a BS in chemistry and biochemistry, a PhD in molecular biology from the University of Illinois at Chicago. He has worked at AbboU and Ortho Clinical Diagnostics in the US and focuses now on start-ups. He was the CEO of InOvo and chairs the board of Venomtech in the UK.
- Founders: 50,34%
- Private Investors: 4,56%
- Financial Investors: 37,73 %
- Industrials: 7,37%